Annual D&A
$554.00 K
+$127.00 K+29.74%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual depreciation & amortization is currently $554.00 thousand, with the most recent change of +$127.00 thousand (+29.74%) on 31 December 2023. During the last 3 years, it has fallen by -$2.38 million (-81.12%). LXRX annual D&A is now -97.43% below its all-time high of $21.53 million, reached on 31 December 2003.LXRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$126.00 K
-$13.00 K-9.35%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly depreciation & amortization is currently $126.00 thousand, with the most recent change of -$13.00 thousand (-9.35%) on 30 September 2024. Over the past year, it has dropped by -$25.00 thousand (-16.56%). LXRX quarterly D&A is now -98.99% below its all-time high of $12.46 million, reached on 31 March 2000.LXRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$556.00 K
-$25.00 K-4.30%
30 September 2024
Summary:
Lexicon Pharmaceuticals TTM depreciation & amortization is currently $556.00 thousand, with the most recent change of -$25.00 thousand (-4.30%) on 30 September 2024. Over the past year, it has increased by +$46.00 thousand (+9.02%). LXRX TTM D&A is now -97.43% below its all-time high of $21.59 million, reached on 30 September 2003.LXRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.7% | -16.6% | +9.0% |
| 3 y3 years | -81.1% | +24.8% | +6.1% |
| 5 y5 years | -85.0% | -86.1% | -84.7% |
LXRX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.1% | +89.7% | -16.6% | +24.8% | -5.1% | +90.4% |
| 5 y | 5 years | -85.0% | +89.7% | -86.5% | +240.5% | -84.8% | +90.4% |
| alltime | all time | -97.4% | +89.7% | -99.0% | +100.7% | -97.4% | +109.0% |
Lexicon Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $126.00 K(-9.4%) | $556.00 K(-4.3%) |
| June 2024 | - | $139.00 K(-3.5%) | $581.00 K(-0.9%) |
| Mar 2024 | - | $144.00 K(-2.0%) | $586.00 K(+5.8%) |
| Dec 2023 | $554.00 K(+29.7%) | $147.00 K(-2.6%) | $554.00 K(+8.6%) |
| Sept 2023 | - | $151.00 K(+4.9%) | $510.00 K(+9.2%) |
| June 2023 | - | $144.00 K(+28.6%) | $467.00 K(+8.6%) |
| Mar 2023 | - | $112.00 K(+8.7%) | $430.00 K(+0.7%) |
| Dec 2022 | $427.00 K(+46.2%) | $103.00 K(-4.6%) | $427.00 K(-2.1%) |
| Sept 2022 | - | $108.00 K(+0.9%) | $436.00 K(+1.6%) |
| June 2022 | - | $107.00 K(-1.8%) | $429.00 K(+17.9%) |
| Mar 2022 | - | $109.00 K(-2.7%) | $364.00 K(+24.7%) |
| Dec 2021 | $292.00 K(-90.0%) | $112.00 K(+10.9%) | $292.00 K(-44.3%) |
| Sept 2021 | - | $101.00 K(+140.5%) | $524.00 K(-56.6%) |
| June 2021 | - | $42.00 K(+13.5%) | $1.21 M(-41.5%) |
| Mar 2021 | - | $37.00 K(-89.2%) | $2.06 M(-29.6%) |
| Dec 2020 | $2.93 M(-19.7%) | $344.00 K(-56.1%) | $2.93 M(-16.8%) |
| Sept 2020 | - | $784.00 K(-12.9%) | $3.52 M(-3.4%) |
| June 2020 | - | $900.00 K(-0.7%) | $3.65 M(-0.3%) |
| Mar 2020 | - | $906.00 K(-3.1%) | $3.66 M(+0.1%) |
| Dec 2019 | $3.65 M(-0.8%) | $935.00 K(+3.0%) | $3.65 M(+0.6%) |
| Sept 2019 | - | $908.00 K(-0.2%) | $3.63 M(-0.3%) |
| June 2019 | - | $910.00 K(+1.0%) | $3.64 M(-0.5%) |
| Mar 2019 | - | $901.00 K(-1.2%) | $3.66 M(-0.7%) |
| Dec 2018 | $3.68 M(+8.4%) | $912.00 K(-0.7%) | $3.68 M(-0.3%) |
| Sept 2018 | - | $918.00 K(-1.1%) | $3.69 M(-0.1%) |
| June 2018 | - | $928.00 K(+0.3%) | $3.70 M(+0.3%) |
| Mar 2018 | - | $925.00 K(+0.1%) | $3.69 M(+8.6%) |
| Dec 2017 | $3.40 M(+65.3%) | $924.00 K(+0.1%) | $3.40 M(+13.9%) |
| Sept 2017 | - | $923.00 K(+0.5%) | $2.98 M(+16.0%) |
| June 2017 | - | $918.00 K(+44.8%) | $2.57 M(+18.5%) |
| Mar 2017 | - | $634.00 K(+24.8%) | $2.17 M(+5.5%) |
| Dec 2016 | $2.06 M(+182.8%) | $508.00 K(-0.6%) | $2.06 M(+27.4%) |
| Sept 2016 | - | $511.00 K(-1.0%) | $1.61 M(+38.8%) |
| June 2016 | - | $516.00 K(-1.0%) | $1.16 M(+30.2%) |
| Mar 2016 | - | $521.00 K(+689.4%) | $893.00 K(+22.8%) |
| Dec 2015 | $727.00 K(-62.3%) | $66.00 K(+10.0%) | $727.00 K(-16.0%) |
| Sept 2015 | - | $60.00 K(-75.6%) | $865.00 K(-35.0%) |
| June 2015 | - | $246.00 K(-30.7%) | $1.33 M(-18.8%) |
| Mar 2015 | - | $355.00 K(+74.0%) | $1.64 M(-15.0%) |
| Dec 2014 | $1.93 M(-32.7%) | $204.00 K(-61.2%) | $1.93 M(-19.4%) |
| Sept 2014 | - | $526.00 K(-5.1%) | $2.39 M(-2.0%) |
| June 2014 | - | $554.00 K(-14.0%) | $2.44 M(-10.0%) |
| Mar 2014 | - | $644.00 K(-3.7%) | $2.71 M(-5.2%) |
| Dec 2013 | $2.86 M(-31.7%) | $669.00 K(+16.1%) | $2.86 M(-7.9%) |
| Sept 2013 | - | $576.00 K(-30.2%) | $3.11 M(-13.3%) |
| June 2013 | - | $825.00 K(+4.0%) | $3.59 M(-7.0%) |
| Mar 2013 | - | $793.00 K(-13.4%) | $3.86 M(-7.9%) |
| Dec 2012 | $4.19 M | $916.00 K(-13.2%) | $4.19 M(-5.0%) |
| Sept 2012 | - | $1.05 M(-3.6%) | $4.41 M(-2.8%) |
| June 2012 | - | $1.09 M(-2.8%) | $4.54 M(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $1.13 M(-0.9%) | $4.71 M(-3.7%) |
| Dec 2011 | $4.89 M(-9.4%) | $1.14 M(-3.9%) | $4.89 M(-3.5%) |
| Sept 2011 | - | $1.18 M(-6.6%) | $5.06 M(-3.0%) |
| June 2011 | - | $1.26 M(-3.3%) | $5.22 M(-1.9%) |
| Mar 2011 | - | $1.31 M(-0.4%) | $5.32 M(-1.4%) |
| Dec 2010 | $5.39 M(-12.4%) | $1.31 M(-1.9%) | $5.39 M(-1.6%) |
| Sept 2010 | - | $1.34 M(-2.1%) | $5.48 M(-1.9%) |
| June 2010 | - | $1.36 M(-1.1%) | $5.59 M(-3.1%) |
| Mar 2010 | - | $1.38 M(-1.4%) | $5.77 M(-6.4%) |
| Dec 2009 | $6.16 M(-22.3%) | $1.40 M(-3.0%) | $6.16 M(-7.1%) |
| Sept 2009 | - | $1.44 M(-6.6%) | $6.63 M(-6.8%) |
| June 2009 | - | $1.54 M(-12.8%) | $7.12 M(-6.9%) |
| Mar 2009 | - | $1.77 M(-5.3%) | $7.64 M(-3.6%) |
| Dec 2008 | $7.93 M(-23.9%) | $1.87 M(-3.0%) | $7.93 M(-15.1%) |
| Sept 2008 | - | $1.93 M(-6.8%) | $9.34 M(-3.1%) |
| June 2008 | - | $2.07 M(+0.6%) | $9.63 M(-3.8%) |
| Mar 2008 | - | $2.06 M(-37.3%) | $10.01 M(-3.9%) |
| Dec 2007 | $10.42 M(-7.0%) | $3.28 M(+47.7%) | $10.42 M(+7.3%) |
| Sept 2007 | - | $2.22 M(-9.2%) | $9.71 M(-4.5%) |
| June 2007 | - | $2.45 M(-0.9%) | $10.18 M(-4.8%) |
| Mar 2007 | - | $2.47 M(-4.2%) | $10.69 M(-4.6%) |
| Dec 2006 | $11.20 M(-3.7%) | $2.58 M(-4.1%) | $11.20 M(-3.0%) |
| Sept 2006 | - | $2.69 M(-9.3%) | $11.55 M(-2.1%) |
| June 2006 | - | $2.96 M(-0.8%) | $11.79 M(+0.4%) |
| Mar 2006 | - | $2.98 M(+2.1%) | $11.74 M(+0.9%) |
| Dec 2005 | $11.63 M(-9.6%) | $2.92 M(-0.3%) | $11.63 M(-2.1%) |
| Sept 2005 | - | $2.93 M(+0.5%) | $11.88 M(+0.7%) |
| June 2005 | - | $2.91 M(+1.4%) | $11.80 M(+0.1%) |
| Mar 2005 | - | $2.87 M(-9.3%) | $11.79 M(-8.4%) |
| Dec 2004 | $12.87 M(-40.2%) | $3.17 M(+11.4%) | $12.87 M(-14.5%) |
| Sept 2004 | - | $2.85 M(-2.1%) | $15.06 M(-14.6%) |
| June 2004 | - | $2.91 M(-26.4%) | $17.63 M(-12.3%) |
| Mar 2004 | - | $3.95 M(-26.2%) | $20.10 M(-6.6%) |
| Dec 2003 | $21.53 M(+4.6%) | $5.36 M(-1.2%) | $21.53 M(-0.3%) |
| Sept 2003 | - | $5.42 M(+0.8%) | $21.59 M(+0.7%) |
| June 2003 | - | $5.38 M(-0.1%) | $21.44 M(+1.4%) |
| Mar 2003 | - | $5.38 M(-0.7%) | $21.15 M(+2.8%) |
| Dec 2002 | $20.58 M(+24.3%) | $5.42 M(+3.0%) | $20.58 M(+3.2%) |
| Sept 2002 | - | $5.26 M(+3.4%) | $19.93 M(+5.1%) |
| June 2002 | - | $5.09 M(+5.8%) | $18.97 M(+7.4%) |
| Mar 2002 | - | $4.81 M(+0.8%) | $17.67 M(+6.7%) |
| Dec 2001 | $16.55 M(+531.4%) | $4.77 M(+11.0%) | $16.55 M(-393.0%) |
| Sept 2001 | - | $4.30 M(+13.6%) | -$5.65 M(-8.8%) |
| June 2001 | - | $3.79 M(+2.5%) | -$6.20 M(+0.8%) |
| Mar 2001 | - | $3.69 M(-121.2%) | -$6.15 M(-334.6%) |
| Dec 2000 | $2.62 M(+31.1%) | -$17.43 M(-564.5%) | $2.62 M(-86.9%) |
| Sept 2000 | - | $3.75 M(-2.1%) | $20.05 M(+23.0%) |
| June 2000 | - | $3.83 M(-69.2%) | $16.29 M(+30.8%) |
| Mar 2000 | - | $12.46 M | $12.46 M |
| Dec 1999 | $2.00 M | - | - |
FAQ
- What is Lexicon Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual D&A year-on-year change?
- What is Lexicon Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly D&A year-on-year change?
- What is Lexicon Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals TTM D&A year-on-year change?
What is Lexicon Pharmaceuticals annual depreciation & amortization?
The current annual D&A of LXRX is $554.00 K
What is the all time high annual D&A for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual depreciation & amortization is $21.53 M
What is Lexicon Pharmaceuticals annual D&A year-on-year change?
Over the past year, LXRX annual depreciation & amortization has changed by +$127.00 K (+29.74%)
What is Lexicon Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of LXRX is $126.00 K
What is the all time high quarterly D&A for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly depreciation & amortization is $12.46 M
What is Lexicon Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, LXRX quarterly depreciation & amortization has changed by -$25.00 K (-16.56%)
What is Lexicon Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of LXRX is $556.00 K
What is the all time high TTM D&A for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high TTM depreciation & amortization is $21.59 M
What is Lexicon Pharmaceuticals TTM D&A year-on-year change?
Over the past year, LXRX TTM depreciation & amortization has changed by +$46.00 K (+9.02%)